Author

E.P. Hamilton

Observed names: E Hamilton, E. Hamilton, E. P. Hamilton, EP Hamilton
Institution: Sarah Cannon
Observed institutions: Semmelweis University, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Harvard University, University of Antwerp, University of Liège, University of California, Los Angeles, Merck KGaA, Darmstadt (Germany), Eli Lilly (United States), Duke University, Sarah Cannon Research Institute, University of Alabama, Wayne State University, Washington University in St. Louis, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Texas Oncology, Peter MacCallum Cancer Centre, London Health Sciences Centre, Jewish General Hospital, Yale Cancer Center, Hospital General Universitario Gregorio Marañón, Moffitt Cancer Center, University of Alabama at Birmingham, Yale University, Massachusetts General Hospital, The Barbara Ann Karmanos Cancer Institute, Hospital Clínico Universitario de Valencia, Zymeworks (Canada), Sarah Cannon, EMD Serono, Inc. (United States), Dana-Farber Cancer Institute, Florida Cancer Specialists & Research Institute, South Texas Accelerated Research Therapeutics, Vall d'Hebron Hospital Universitari, University of Colorado Cancer Center, Clinica Universidad de Navarra, Tennessee Oncology, Hospital Universitario HM Sanchinarro, Northwest Medical Specialties, Mersana Therapeutics (United States), Vanderbilt-Ingram Cancer Center, Winship Cancer Institute, Duke Cancer Institute, Merck Healthcare KGaA, Darmstadt (Germany), Hôpital de la Cité-de-la-Santé, The Ohio State University, Vanderbilt University Medical Center
OpenAlex ID: A5030628808
2021 · J. O'Shaughnessy, P. Rastogi, et al. · Annals of Oncology · 9
Works count: 89
Citation count: 1,948
H-index: 12
I10-index: 16
Year
Topic
Type